Search research articles
Contact Us
Filters
Showing results (401-410 of 737) with videos related to
Page
of 74
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
March 16, 2007
A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda
John D Phillips, Hector A Bergonia, Christopher A Reilly, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
January 8, 2008
Effects of cell type and culture media on Interleukin-6 secretion in response to environmental particles
John M Veranth, N Shane Cutler, Erin G Kaser, et al.
Neurochemical Research
|
December 13, 2006
Analysis of plasma biopterin levels in psychiatric disorders suggests a common BH4 deficit in schizophrenia and schizoaffective disorder
Mary Ann Richardson, Laura L Read, Margaret A Reilly, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
July 22, 2022
Parenchymal and Inflammatory Cell Responses to Single and Repeated Ozone Exposure in Healthy and Surfactant Protein-C Mutant Lung
Jacklyn Nguyen, Cassandra E Deering-Rice, Brittnie S Armstrong, et al.
The Veterinary Record
|
February 22, 1997
Thrombotic meningoencephalitis associated with Histophilus ovis infection in lambs in Europe
J P Cassidy, S W McDowell, G A Reilly, et al.
European Journal of Biochemistry
|
February 15, 1994
Purification and characterization of the periplasmic nitrate reductase from Thiosphaera pantotropha
B C Berks, D J Richardson, C Robinson, et al.
Polish Archives of Internal Medicine
|
February 2, 2017
Successful use of idarucizumab as a reversal agent for dabigatran in a patient with acute dissected aortic aneurysm
Anna Tomaszuk-Kazberuk, Paulina Łopatowska, Elżbieta Młodawska, et al.
Journal of the American College of Cardiology
|
May 13, 2014
Reply: regarding the effect of dabigatran plasma concentrations
Paul A Reilly, Stuart J Connolly, Salim Yusuf, et al.
British Journal of Clinical Pharmacology
|
February 22, 2012
Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin
Sebastian Härtter, Michael Koenen-Bergmann, Ashish Sharma, et al.
Journal of Clinical Pharmacology
|
September 30, 2011
Dabigatran etexilate in atrial fibrillation patients with severe renal impairment: dose identification using pharmacokinetic modeling and simulation
Thorsten Lehr, Sebastian Haertter, Karl-Heinz Liesenfeld, et al.
Page
of 74
Search research articles
Search
Showing results (401-410 of 737) with videos related to
Sort By:
Page
of 74
Proceedings of the National Academy of Sciences of the United States of America
|
March 16, 2007
A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda
John D Phillips, Hector A Bergonia, Christopher A Reilly, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
January 8, 2008
Effects of cell type and culture media on Interleukin-6 secretion in response to environmental particles
John M Veranth, N Shane Cutler, Erin G Kaser, et al.
Neurochemical Research
|
December 13, 2006
Analysis of plasma biopterin levels in psychiatric disorders suggests a common BH4 deficit in schizophrenia and schizoaffective disorder
Mary Ann Richardson, Laura L Read, Margaret A Reilly, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
July 22, 2022
Parenchymal and Inflammatory Cell Responses to Single and Repeated Ozone Exposure in Healthy and Surfactant Protein-C Mutant Lung
Jacklyn Nguyen, Cassandra E Deering-Rice, Brittnie S Armstrong, et al.
The Veterinary Record
|
February 22, 1997
Thrombotic meningoencephalitis associated with Histophilus ovis infection in lambs in Europe
J P Cassidy, S W McDowell, G A Reilly, et al.
European Journal of Biochemistry
|
February 15, 1994
Purification and characterization of the periplasmic nitrate reductase from Thiosphaera pantotropha
B C Berks, D J Richardson, C Robinson, et al.
Polish Archives of Internal Medicine
|
February 2, 2017
Successful use of idarucizumab as a reversal agent for dabigatran in a patient with acute dissected aortic aneurysm
Anna Tomaszuk-Kazberuk, Paulina Łopatowska, Elżbieta Młodawska, et al.
Journal of the American College of Cardiology
|
May 13, 2014
Reply: regarding the effect of dabigatran plasma concentrations
Paul A Reilly, Stuart J Connolly, Salim Yusuf, et al.
British Journal of Clinical Pharmacology
|
February 22, 2012
Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin
Sebastian Härtter, Michael Koenen-Bergmann, Ashish Sharma, et al.
Journal of Clinical Pharmacology
|
September 30, 2011
Dabigatran etexilate in atrial fibrillation patients with severe renal impairment: dose identification using pharmacokinetic modeling and simulation
Thorsten Lehr, Sebastian Haertter, Karl-Heinz Liesenfeld, et al.
Page
of 74